Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Novel allosteric modulators of muscarinic receptors for psoriasis and other disorders

Aug. 19, 2004

Zimycan meets endpoints in phase III study for Candida diaper dermatitis

Aug. 16, 2004

New aminobenzophenone prodrugs and their use in skin inflammatory disorders

Aug. 16, 2004

Sculptra receives FDA approval for lipoatrophy

Aug. 9, 2004

Novel small molecule immunomodulating agent for eczema/psoriasis therapy

Aug. 5, 2004

TRX4 evaluated in new phase I study for psoriasis

Aug. 5, 2004

Positive European opinion for use of Enbrel in psoriasis

Aug. 3, 2004

Preliminary 30-month data show benefit of Raptiva in psoriasis

Aug. 2, 2004

Neurokinin 1 receptor antagonist effective against postoperative fibrous adhesions

July 30, 2004

PediaMed and Allergan enter pediatrics copromotion agreement for Tazorac

July 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...